The Rockefeller University Clinical Scholars (KL2) program 2006–2016
Introduction and Methods The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program....
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2017-10-01
|
Series: | Journal of Clinical and Translational Science |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866117003089/type/journal_article |
_version_ | 1811156853143371776 |
---|---|
author | Sarah J. Schlesinger Michelle Romanick Jonathan N. Tobin Donna Brassil Rhonda G. Kost Rita Devine Barbara O’Sullivan Roger D. Vaughan Yupu Liang Joel Correa da Rosa Maija Williams James G. Krueger Barry S. Coller |
author_facet | Sarah J. Schlesinger Michelle Romanick Jonathan N. Tobin Donna Brassil Rhonda G. Kost Rita Devine Barbara O’Sullivan Roger D. Vaughan Yupu Liang Joel Correa da Rosa Maija Williams James G. Krueger Barry S. Coller |
author_sort | Sarah J. Schlesinger |
collection | DOAJ |
description |
Introduction and Methods
The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program. The program consists of ∼15 trainees supported by the Clinical and Translational Science Award KL2 award and University funds. It is designed to provide an optimal environment for junior translational investigators to develop team science and leadership skills by designing and performing a human subjects protocol under the supervision of a distinguished senior investigator mentor and a team of content expert educators. This is complemented by a tutorial focused on important translational skills.
Results
Since 2006, 40 Clinical Scholars have graduated from the programs and gone on to careers in academia (72%), government service (5%), industry (15%), and private medical practice (3%); 2 (5%) remain in training programs; 39/40 remain in translational research careers with 23 National Institute of Health awards totaling $23 million, foundation and philanthropic support of $20.3 million, and foreign government and foundation support of $6 million. They have made wide ranging scientific discoveries and have endeavored to translate those discoveries into improved human health.
Conclusion
The Rockefeller Clinical Scholars (KL2) program provides one model for translational science training.
|
first_indexed | 2024-04-10T04:58:03Z |
format | Article |
id | doaj.art-677a2c7991f24b4ca0836dd7348348af |
institution | Directory Open Access Journal |
issn | 2059-8661 |
language | English |
last_indexed | 2024-04-10T04:58:03Z |
publishDate | 2017-10-01 |
publisher | Cambridge University Press |
record_format | Article |
series | Journal of Clinical and Translational Science |
spelling | doaj.art-677a2c7991f24b4ca0836dd7348348af2023-03-09T12:29:34ZengCambridge University PressJournal of Clinical and Translational Science2059-86612017-10-01128529110.1017/cts.2017.308The Rockefeller University Clinical Scholars (KL2) program 2006–2016Sarah J. Schlesinger0Michelle Romanick1Jonathan N. Tobin2Donna Brassil3Rhonda G. Kost4Rita Devine5Barbara O’Sullivan6Roger D. Vaughan7Yupu Liang8Joel Correa da Rosa9Maija Williams10James G. Krueger11Barry S. Coller12Center for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USA Clinical Directors Network, Inc., New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USA Department of Biostatistics, Columbia University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USACenter for Clinical and Translational Science, Rockefeller University, New York, NY, USA Introduction and Methods The Rockefeller Clinical Scholars (KL2) program began in 1976 and transitioned into a 3-year Master’s degree program in 2006 when Rockefeller joined the National Institute of Health Clinical and Translational Science Award program. The program consists of ∼15 trainees supported by the Clinical and Translational Science Award KL2 award and University funds. It is designed to provide an optimal environment for junior translational investigators to develop team science and leadership skills by designing and performing a human subjects protocol under the supervision of a distinguished senior investigator mentor and a team of content expert educators. This is complemented by a tutorial focused on important translational skills. Results Since 2006, 40 Clinical Scholars have graduated from the programs and gone on to careers in academia (72%), government service (5%), industry (15%), and private medical practice (3%); 2 (5%) remain in training programs; 39/40 remain in translational research careers with 23 National Institute of Health awards totaling $23 million, foundation and philanthropic support of $20.3 million, and foreign government and foundation support of $6 million. They have made wide ranging scientific discoveries and have endeavored to translate those discoveries into improved human health. Conclusion The Rockefeller Clinical Scholars (KL2) program provides one model for translational science training. https://www.cambridge.org/core/product/identifier/S2059866117003089/type/journal_articleTranslational researchTrainingKL2master’s degree |
spellingShingle | Sarah J. Schlesinger Michelle Romanick Jonathan N. Tobin Donna Brassil Rhonda G. Kost Rita Devine Barbara O’Sullivan Roger D. Vaughan Yupu Liang Joel Correa da Rosa Maija Williams James G. Krueger Barry S. Coller The Rockefeller University Clinical Scholars (KL2) program 2006–2016 Journal of Clinical and Translational Science Translational research Training KL2 master’s degree |
title | The Rockefeller University Clinical Scholars (KL2) program 2006–2016 |
title_full | The Rockefeller University Clinical Scholars (KL2) program 2006–2016 |
title_fullStr | The Rockefeller University Clinical Scholars (KL2) program 2006–2016 |
title_full_unstemmed | The Rockefeller University Clinical Scholars (KL2) program 2006–2016 |
title_short | The Rockefeller University Clinical Scholars (KL2) program 2006–2016 |
title_sort | rockefeller university clinical scholars kl2 program 2006 2016 |
topic | Translational research Training KL2 master’s degree |
url | https://www.cambridge.org/core/product/identifier/S2059866117003089/type/journal_article |
work_keys_str_mv | AT sarahjschlesinger therockefelleruniversityclinicalscholarskl2program20062016 AT michelleromanick therockefelleruniversityclinicalscholarskl2program20062016 AT jonathanntobin therockefelleruniversityclinicalscholarskl2program20062016 AT donnabrassil therockefelleruniversityclinicalscholarskl2program20062016 AT rhondagkost therockefelleruniversityclinicalscholarskl2program20062016 AT ritadevine therockefelleruniversityclinicalscholarskl2program20062016 AT barbaraosullivan therockefelleruniversityclinicalscholarskl2program20062016 AT rogerdvaughan therockefelleruniversityclinicalscholarskl2program20062016 AT yupuliang therockefelleruniversityclinicalscholarskl2program20062016 AT joelcorreadarosa therockefelleruniversityclinicalscholarskl2program20062016 AT maijawilliams therockefelleruniversityclinicalscholarskl2program20062016 AT jamesgkrueger therockefelleruniversityclinicalscholarskl2program20062016 AT barryscoller therockefelleruniversityclinicalscholarskl2program20062016 AT sarahjschlesinger rockefelleruniversityclinicalscholarskl2program20062016 AT michelleromanick rockefelleruniversityclinicalscholarskl2program20062016 AT jonathanntobin rockefelleruniversityclinicalscholarskl2program20062016 AT donnabrassil rockefelleruniversityclinicalscholarskl2program20062016 AT rhondagkost rockefelleruniversityclinicalscholarskl2program20062016 AT ritadevine rockefelleruniversityclinicalscholarskl2program20062016 AT barbaraosullivan rockefelleruniversityclinicalscholarskl2program20062016 AT rogerdvaughan rockefelleruniversityclinicalscholarskl2program20062016 AT yupuliang rockefelleruniversityclinicalscholarskl2program20062016 AT joelcorreadarosa rockefelleruniversityclinicalscholarskl2program20062016 AT maijawilliams rockefelleruniversityclinicalscholarskl2program20062016 AT jamesgkrueger rockefelleruniversityclinicalscholarskl2program20062016 AT barryscoller rockefelleruniversityclinicalscholarskl2program20062016 |